Drugs / RO5011232
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01483469 | Dec 2011 → Oct 2013 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5011232 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01483469 ↗ |
| Modality | Diagnostic / imaging agent | “\[11C\]-RO5011232 as radiotracer” NCT01483469 ↗ |
| Route | Intravenous | “\[11C\]-RO5011232 intravenously” NCT01483469 ↗ |